IPC Statement - Adverse Analytical Finding Reported on German
Beijing, China – The International Paralympic Committee (IPC) and the International Wheelchair Basketball Federation (IWBF) yesterday were informed about an adverse analytical finding (positive laboratory test) of German Wheelchair Basketball player Ahmet Coskun, who failed an out-of-competition test performed by the German National Doping Agency (NADA) on 23 August 2008 during a training camp in Germany. He was tested positive for the prohibited substance of Finasterid, a non-performance enhancement medication.
11 Sep 2008
The German Paralympic Committee immediately banned the athlete from any further competition and has made arrangements for the athlete to be sent home. According to IWBF rules, the outcome has neither an impact on further proceedings of the Wheelchair Basketball event nor the results of the Games in Beijing. The case is going to be further investigated by the German National Doping Agency and IWBF.
The IPC and IWBF appreciate the immediate actions taken by the German National Paralympic Committee in regards to this possible anti-doping rule violation in the sport of Wheelchair Basketball.
As a signatory of the World Anti-Doping Code (WADC), the IPC and IWBF remain committed to a doping free sporting environment at all levels. The IPC, together with the International Federations and the National Paralympic Committees, established the IPC Anti-Doping Code (January 2004) to prevent in the spirit of fair play, doping in sport for athletes with a disability and in conformity with the general principles of the World Anti-Doping Code.